Stratum now has exclusive rights to distribute Clasado Biosciences’ Bimuno GOS in the U.S. and Canadian markets.
Clasado Biosciences (Berkshire, UK) has granted exclusive rights to Stratum Nutrition (Carthage, MO) to distribute Clasado’s Bimuno GOS galactooligosaccharide prebiotic ingredient in the U.S. and Canadian markets.
In a press release, Frederic Narbel, vice president of B2B sales at Clasado, stated, “With consumer interest in prebiotics accelerating across North America, the future of health and nutrition formulation is an exciting area for microbiome-modulating products.”
Micah Osborne, Stratum’s CEO, added, “We are in the age of gut health innovation, and the commercial potential of prebiotics is significant. Their stability also makes them suitable for a wide range of applications. No longer are they exclusively used in supplements but increasingly in functional food and beverages. We are pleased to add Bimuno GOS to our ingredient portfolio as it aligns with our scientific values, and we look forward to supporting our customers in formulating their own prebiotic product ranges.”
NPA’s lawsuit against FDA on NMN stayed pending agency’s decision on citizen petition
November 6th 2024The court has granted a joint motion for stay filed by NPA and FDA, pending the agency's decision on the citizen petition asking FDA to reverse its stance on NMN's status as a dietary ingredient.
Recent study compares the effectiveness of two probiotic products on colicky infants
October 31st 2024The study compared AB-Biotics and Kaneka Probiotics’ probiotic formulation of Bifidobacterium longum KABP®-042 and Pediococcus pentosaceus KABP®-041 to Lactobacillus reuteri DSM17938 (LR) from Biogaia.